Bradykinin-mediated angioedema include angiotensin-converting enzyme (ACE)-inhibitor-induced angioedema, sartan-mediated angioedema, and hereditary angioedema (HAE) as well as angioedema due to acquired C1 inhibitor deficiency. Here, ACE is linked to hereditary angioedema.